Plains Ventures Leads Investment in Biotech Company Cadenza Bio, Inc.

Preclinical biotechnology company initially focusing on therapeutic drug development to promote remyelination in Multiple Sclerosis Oklahoma City, OK – Plains Ventures announced a lead investment in Cadenza Bio, Inc. (Cadenza), a privately-held biotechnology company focused on developing novel small molecule compounds for demyelinating and inflammatory diseases. Cadenza Bio’s initial closing of an oversubscribed $2.44M Series […]